Journal of Pharmaceutical Policy and Practice

Titel Veröffentlichungsdatum Sprache Zitate
Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland2015/10/05English
Approval, reimbursement and pricing of high-cost cancer medicines in Australia2015/10/05English
Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil2015/10/05English
Availability and prices of essential medicines for chronic diseases in older people in the Asia Pacific Region2015/10/05English
Pharmaceutical policies in Australia and New Zealand2015/10/05English
Development of pharmaceutical prices in the Republic of Macedonia in comparison to selected countries outside the national reference baskets2015/10/05English
Value of generic medicines: an health economics study2015/10/05English
Availability and affordability of medicines for children2015/10/05English
Developing a Drug Price Reference Index in the Philippines2015/10/05English
Exploring the Impact of health-care cost sharing mechanisms in health service users for all the 27 member countries of the EU2015/10/05English
Insurance-based risk-sharing agreements2015/10/05English
Using Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework2015/10/05English
Medicines optimisation in Northern Ireland - scope and results of a challenging project2015/10/05English
A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate2015/10/05English
Cost-Containment of Non-Formulary Medicines Accessibility: Malaysian Experience2015/10/05English
Collaborative models for increasing efficiency of early drug assessment2015/10/05English
Impact of discounts on medicine prices2015/10/05English
Access of high technology medicines in Russia2015/10/05English
Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors2015/10/05English
The 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines?2015/10/05English
Optimising prescribing in primary care: an evaluation of financial and clinical parameters2015/10/05English
Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin2015/10/05English
Priority medicines for Europe and the World: setting a public-health-based medicines development agenda2015/10/05English
Developing the SCM workforce in Nigeria through contextualised pre-service education and continued professional development2014/12/01English
Human resource development in supply chain management- what do the UN agencies say?2014/12/01English
Analysis and findings from the Zimbabwe supply chain human resource assessment2014/12/01English
Development of a sustainable access to medicine model in the Caribbean: a case study of the chronic disease assistance program2014/12/01English
Human resources health supply chains and access to essential medicines2014/12/01English
Pilot projects empower district supply chain management staff to strengthen health services in Indonesia2014/12/01English
Assessment of the nevirapine safety signal using data from the national antiretroviral dispensing database: a retrospective study2016/02/15English